Invisible Sentinel was founded in 2006 by Benjamin Pascal, the CEO, andNicholas Siciliano, the company’s co-founder and chief operating officer, to develop novel, point-of-care diagnostic systems for the detection of microbial pathogens in the food supply. It employs eight in Philadelphia.
Major milestones: To date, Invisible Sentinel has recruited talented and accomplished scientists, raised $4 million from angel investors, and received its first patent, on Sept. 6, 2011. The company was selected by the U.S. and Chinese governments to travel to China as part of an envoy of diagnostic experts to explore methods to improve food quality and safety in China. The company has agreements from manufacturers and processors to alpha/beta test products and has received third party-validations for its diagnostic systems. It has also developed customized diagnostic platforms based on user requirements and field applications. The company has established an animal facility at The University of the Sciences and attracted interest from several potential strategic partners.
Top company goals for 2012: Invisible Sentinel is looking forward to launching its food-borne diseases diagnostic portfolio in 2012. The company intends to continue to explore out-licensing and strategic partnering opportunities, optimize manufacturing capabilities, scale up marketing and sales strategies and meet 2012 revenue projections.
